Importance of target-mediated drug disposition for small molecules
- 1 December 2018
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 23 (12) , 2023-2030
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survivalDrug Discovery Today, 2012
- Evacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressureJournal of Lipid Research, 2011
- Impact of Target‐Mediated Drug Disposition on Linagliptin Pharmacokinetics and DPP‐4 Inhibition in Type 2 Diabetic PatientsThe Journal of Clinical Pharmacology, 2010
- Miniaturized Receptor Binding Assays: Complications Arising from Ligand DepletionSLAS Discovery, 2007
- Use of microdosing to predict pharmacokinetics at the therapeutic dose: Experience with 5 drugsClinical Pharmacology & Therapeutics, 2006
- A Novel Strategy for Physiologically Based Predictions of Human PharmacokineticsClinical Pharmacokinetics, 2006
- Comparative pharmacokinetics of coumarin anticoagulants L: Physiologic modeling of S-warfarin in rats and pharmacologic target-mediated warfarin disposition in manJournal of Pharmaceutical Sciences, 2003
- Multiple-Dose Pharmacokinetics of Selegiline and Desmethylselegiline Suggest Saturable Tissue BindingClinical Neuropharmacology, 2000
- Pharmacokinetics of AlendronateClinical Pharmacokinetics, 1999
- Comparative Pharmacokinetics of Coumarin Anticoagulants XLIX: Nonlinear Tissue Distribution of S-Warfarin in RatsJournal of Pharmaceutical Sciences, 1989